Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 Dec;82(23):7974–7978. doi: 10.1073/pnas.82.23.7974

Milrinone and thyroid hormone stimulate myocardial membrane Ca2+-ATPase activity and share structural homologies.

K M Mylotte, V Cody, P J Davis, F B Davis, S D Blas, M Schoenl
PMCID: PMC391424  PMID: 2933747

Abstract

We have recently shown that thyroid hormone in physiological concentrations stimulates sarcolemma-enriched rabbit-myocardial-membrane Ca2+-ATPase in vitro. In this study, milrinone [2-methyl-5-cyano-(3,4'-bipyridin)-6(1H)-one], a cardiac inotropic agent, was thyromimetic in the same system. At clinically achievable concentrations (50-500 nM), milrinone significantly stimulated membrane Ca2+-ATPase in vitro. This action was antagonized by W-7 [N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide], an agent that also blocks thyroid hormone action on the Ca2+-ATPase, at concentrations as low as 5 microM. Progressive additions of milrinone to membranes incubated with a fixed concentration of thyroxine (0.10 nM) or triiodothyronine resulted in a progressive obliteration of the thyroid hormone effect on Ca2+-ATPase. Amrinone [5-amino-(3,4'-bipyridin)-6(1H)-one], the parent bipyridine of milrinone, had no effect on myocardial Ca2+-ATPase activity. X-ray crystallographic analysis of milrinone and amrinone revealed structural homologies between the phenolic ring of thyroxine and the substituted ring of milrinone, whereas amrinone did not share these homologies. The mechanism(s) of the inotropic actions of thyroxine and of milrinone is not clearly understood, but these observations implicate Ca2+-ATPase, a calcium pump-associated enzyme, as one mediator of the effects on the heart of these two compounds.

Full text

PDF
7974

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alousi A. A., Farah A. E., Lesher G. Y., Opalka C. J., Jr Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one]. Circ Res. 1979 Nov;45(5):666–677. doi: 10.1161/01.res.45.5.666. [DOI] [PubMed] [Google Scholar]
  2. Baim D. S., McDowell A. V., Cherniles J., Monrad E. S., Parker J. A., Edelson J., Braunwald E., Grossman W. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. N Engl J Med. 1983 Sep 29;309(13):748–756. doi: 10.1056/NEJM198309293091302. [DOI] [PubMed] [Google Scholar]
  3. Benotti J. R., Grossman W., Braunwald E., Davolos D. D., Alousi A. A. Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med. 1978 Dec 21;299(25):1373–1377. doi: 10.1056/NEJM197812212992501. [DOI] [PubMed] [Google Scholar]
  4. Caroni P., Carafoli E. The Ca2+-pumping ATPase of heart sarcolemma. Characterization, calmodulin dependence, and partial purification. J Biol Chem. 1981 Apr 10;256(7):3263–3270. [PubMed] [Google Scholar]
  5. Davis F. B., Cody V., Davis P. J., Borzynski L. J., Blas S. D. Stimulation by thyroid hormone analogues of red blood cell Ca2+-ATPase activity in vitro. Correlations between hormone structure and biological activity in a human cell system. J Biol Chem. 1983 Oct 25;258(20):12373–12377. [PubMed] [Google Scholar]
  6. Davis F. B., Davis P. J., Blas S. D. Role of calmodulin in thyroid hormone stimulation in vitro of human erythrocyte Ca2+-ATPase activity. J Clin Invest. 1983 Mar;71(3):579–586. doi: 10.1172/JCI110803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davis F. B., Kite J. H., Jr, Davis P. J., Blas S. D. Thyroid hormone stimulation in vitro of red blood cell Ca2+-ATPase activity: interspecies variation. Endocrinology. 1982 Jan;110(1):297–298. doi: 10.1210/endo-110-1-297. [DOI] [PubMed] [Google Scholar]
  8. Davis F. B., Middleton E., Jr, Davis P. J., Blas S. D. Inhibition by quercetin of thyroid hormone stimulation in vitro of human red blood cell Ca2+-ATPase activity. Cell Calcium. 1983 Apr;4(2):71–81. doi: 10.1016/0143-4160(83)90036-2. [DOI] [PubMed] [Google Scholar]
  9. Davis P. J., Blas S. D. In vitro stimulation of human red blood cell Ca2+-ATPase by thyroid hormone. Biochem Biophys Res Commun. 1981 Apr 30;99(4):1073–1080. doi: 10.1016/0006-291x(81)90728-2. [DOI] [PubMed] [Google Scholar]
  10. Davis P. J., Handwerger B. S., Gregerman R. I. Thyroid hormone binding by human serum prealbumin (TBPA). Electrophoretic studies of triiodothyronine-TBPA interaction. J Clin Invest. 1972 Mar;51(3):515–521. doi: 10.1172/JCI106839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dillmann W. H., Berry S., Alexander N. M. A physiological dose of triiodothyronine normalizes cardiac myosin adenosine triphosphatase activity and changes myosin isoenzyme distribution in semistarved rats. Endocrinology. 1983 Jun;112(6):2081–2087. doi: 10.1210/endo-112-6-2081. [DOI] [PubMed] [Google Scholar]
  12. Endoh M., Yamashita S., Taira N. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther. 1982 Jun;221(3):775–783. [PubMed] [Google Scholar]
  13. Hermiller J. B., Leithe M. E., Magorien R. D., Unverferth D. V., Leier C. V. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. J Pharmacol Exp Ther. 1984 Feb;228(2):319–326. [PubMed] [Google Scholar]
  14. Hidaka H., Sasaki Y., Tanaka T., Endo T., Ohno S., Fujii Y., Nagata T. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4354–4357. doi: 10.1073/pnas.78.7.4354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Honerjäger P., Schäfer-Korting M., Reiter M. Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn Schmiedebergs Arch Pharmacol. 1981 Dec;318(2):112–120. doi: 10.1007/BF00508835. [DOI] [PubMed] [Google Scholar]
  16. Jones L. R., Besch H. R., Jr, Fleming J. W., McConnaughey M. M., Watanabe A. M. Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. Comparative biochemical analysis of component activities. J Biol Chem. 1979 Jan 25;254(2):530–539. [PubMed] [Google Scholar]
  17. Klein I., Levey G. S. New perspectives on thyroid hormone, catecholamines, and the heart. Am J Med. 1984 Feb;76(2):167–172. doi: 10.1016/0002-9343(84)90768-x. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Pastelin G., Mendez R., Kabela E., Farah A. The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog. Life Sci. 1983 Oct 31;33(18):1787–1796. doi: 10.1016/0024-3205(83)90686-0. [DOI] [PubMed] [Google Scholar]
  20. Rudinger A., Mylotte K. M., Davis P. J., Davis F. B., Blas S. D. Rabbit myocardial membrane Ca2+-adenosine triphosphatase activity: stimulation in vitro by thyroid hormone. Arch Biochem Biophys. 1984 Feb 15;229(1):379–385. doi: 10.1016/0003-9861(84)90165-6. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES